RECRUITING

Atrial Late Gadolinium Enhancement in Patients With Repaired Congenital Heart Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this research study the investigators want to learn more about how well the investigators can visualize scar tissue in the heart by MRI. In patients with congenital heart disease who need a procedure in the electrophysiology laboratory, how the MRI findings match the findings in the electrophysiology laboratory is not known. This study works to answer these questions. Participants will undergo a cardiac MRI as part of the routine clinical care that was ordered by their doctors and additional imaging by cardiac MRI will be performed.

Official Title

Atrial Late Gadolinium Enhancement in Patients With Repaired Congenital Heart Disease

Quick Facts

Study Start:2022-03-23
Study Completion:2029-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05241418

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients \>13 years old with congenital heart disease referred for cardiac MRI and receiving gadolinium as part of routine clinical care or for pre-ablation planning will be included.
  1. * Those with self-reported anxiety or claustrophobia and/or the presence of a permanent pacemaker or implantable cardioverter defibrillator will be excluded.

Contacts and Locations

Study Contact

Daniel A Castellanos, MD
CONTACT
6173557769
daniel.castellanos@cardio.chboston.org
Edward O'Leary, MD
CONTACT
6173557275
Edward.OLeary@cardio.chboston.org

Principal Investigator

Daniel A Castellanos, MD
PRINCIPAL_INVESTIGATOR
Boston Children's Hospital

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02130
United States

Collaborators and Investigators

Sponsor: Boston Children's Hospital

  • Daniel A Castellanos, MD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-23
Study Completion Date2029-06-30

Study Record Updates

Study Start Date2022-03-23
Study Completion Date2029-06-30

Terms related to this study

Keywords Provided by Researchers

  • Late gadolinium enhancement
  • 3D late gadolinium enhancement
  • atrial late gadolinium enhancement
  • Cardiac MRI
  • Congenital heart disease

Additional Relevant MeSH Terms

  • Congenital Heart Disease
  • Fibrosis Myocardial
  • Fibrosis; Heart